Top compounds associated with response to C22orf31


Feature Type Standardized
Nominal ANOVA
mRNA TL-1-85 GDSC1000 pan-cancer AAC 0.078 0.01
mRNA Mitomycin-C CTRPv2 pan-cancer AAC 0.085 0.01
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.089 0.01
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.088 0.01
mRNA PI-103 CTRPv2 pan-cancer AAC 0.087 0.01
mRNA KIN001-270 GDSC1000 pan-cancer AAC 0.085 0.01
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.084 0.01
mRNA Vorinostat CTRPv2 pan-cancer AAC 0.08 0.01
mRNA BRD-K28456706 CTRPv2 pan-cancer AAC 0.089 0.01
mRNA NVP-ADW742 CTRPv2 pan-cancer AAC 0.085 0.01
Download CSV